Levetiracetam Attenuates Adolescent Stress-induced Behavioral and Electrophysiological Changes Associated With Schizophrenia in Adult Rats
- 21 August 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 49 (1) , 68-77
Abstract
Background and Hypothesis: Stress during adolescence is a major risk factor for schizophrenia. We have found previously in rats that adolescent stress caused, in adulthood, behavioral changes and enhanced ventral tegmental area (VTA) dopamine system activity, which were associated with dysregulation of the excitatory-inhibitory (E/I) balance in the ventral hippocampus (vHip). Levetiracetam, an anticonvulsant drug, regulates the release of neurotransmitters, including glutamate, via SV2A inhibition. It also modulates parvalbumin interneuron activity via Kv3.1 channels. Therefore, levetiracetam could ameliorate deficits in the E/I balance. We tested whether levetiracetam attenuate the adolescent stress-induced behavioral changes, vHip hyperactivity, and enhanced VTA dopamine system activity in adult rats. Study Design: Male Sprague-Dawley rats were subjected to a combination of daily footshock (postnatal day [PD] 31–40), and three 1 h-restraint stress sessions (at PD31, 32, and 40). In adulthood (PD62), animals were tested for anxiety responses (elevated plus-maze and light-dark box), social interaction, and cognitive function (novel object recognition test). The activity of vHip pyramidal neurons and VTA dopamine neurons was also recorded. Study Results: Adolescent stress produced anxiety-like responses and impaired sociability and cognitive function. Levetiracetam (10 mg/kg) reversed these changes. Levetiracetam also reversed the increased VTA dopamine neuron population activity and the enhanced firing rate of vHip pyramidal neurons induced by adolescent stress. Conclusions: These findings suggest that levetiracetam attenuates the adverse outcomes associated with schizophrenia caused by stress during adolescence.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP – 2018/ 17597-3)
- International Brain Research Organization (IBRO Return Home Fellowship
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (FAPESP – 2020/ 04241-6)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (303137/2021-5)
This publication has 58 references indexed in Scilit:
- Prevalence of interpersonal trauma exposure and trauma-related disorders in severe mental illnessEuropean Journal of Psychotraumatology, 2013
- Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive ImpairmentNeuron, 2012
- Levetiracetam Reverses Synaptic Deficits Produced by Overexpression of SV2APLOS ONE, 2011
- Hippocampal interneurons are abnormal in schizophreniaSchizophrenia Research, 2011
- The environment and schizophreniaNature, 2010
- Why do many psychiatric disorders emerge during adolescence?Nature Reviews Neuroscience, 2008
- Unique Properties of Mesoprefrontal Neurons within a Dual Mesocorticolimbic Dopamine SystemNeuron, 2008
- Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complexBrain Research Reviews, 2007
- Role of the ventral subiculum in stress integrationBehavioural Brain Research, 2006
- A review of the validity and variability of the Elevated Plus-Maze as an animal model of anxietyPharmacology Biochemistry and Behavior, 1996